FDA accepts Teva's application for monthly injectable schizophrenia drug.

India launched LuSI, a 2.5 kg AI robot simulating newborn breathing, to improve neonatal care training and reduce infant deaths.

Medicare will now cover FDA-approved multicancer blood/saliva tests, boosting approval efforts despite cost and accuracy challenges.

India's AYUSH federation seeks a national regulator for Yoga and Naturopathy to standardize education and practice.

Eli Lilly's 2025 success driven by diabetes and weight-loss drugs, with key drug advances and major AI investments.

A new U.S. study is testing a promising treatment to reduce swelling in people with hereditary angioedema.

A new TB treatment shows better results and safety than standard therapy in a recent trial.

A 68-year-old Mississippi woman with early Alzheimer’s is using LEQEMBI to slow decline, emphasizing early diagnosis and family.

The Healthcare Leadership Forum 2026 brings 150+ leaders to Mumbai to address India’s healthcare sector shift toward sustainable growth and profitability.

GVRP and Yurogen partner to boost biologics drug discovery in India.